title: In vivo and in vitro structure-activity studies with peptide and pseudopeptide neurotensin analogs suggest the existence of distinct central neurotensin receptor subtypes.
abstract: The present study was designed to compare, with respect to structure-activity relationships, the receptors that subserve the hypothermic and analgesic effects of neurotensin (NT) to the receptor that mediates the effects of NT in mesencephalic dopamine (DA) neurons, and to compare these receptors to the cloned adult rat brain NT receptor and to newborn mouse and rat brain NT receptors. The results show that NT receptors in homogenates from newborn mouse and rat brain and from COS 7 cells transfected with the cloned high-affinity NT receptor from the adult rat brain displayed virtually identical structure-activity relationships toward a series of 12 peptide and pseudopeptide NT analogs, as assessed by the ability of the compounds to inhibit the binding of [125I]NT binding in these systems. Furthermore, when eight of these analogs were tested for their ability to inhibit [125I]NT binding and to potentiate K(+)-evoked DA release in primary cultures of rat mesencephalic neurons, it was found that they all behaved as agonists with binding and biological potencies quite similar to those observed in the other binding assays. Finally and strikingly, when seven of these analogs with checked metabolic stability were tested in vivo for their hypothermic and analgesic (tail-flick test) effects after i.c.v. injection in the mouse, they exhibited relative potencies that were completely different from those obtained in vitro.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Institut de Pharmacologie Moléculaire et Cellulaire du Centre National de la Recherche Scientifique, Université de Nice-Sophia Antipolis, Valbonne, France.
authors.forename: C
authors.initials: C
authors.lastname: Labbé-Jullié
authors.forename: I
authors.initials: I
authors.lastname: Dubuc
authors.forename: A
authors.initials: A
authors.lastname: Brouard
authors.forename: S
authors.initials: S
authors.lastname: Doulut
authors.forename: E
authors.initials: E
authors.lastname: Bourdel
authors.forename: D
authors.initials: D
authors.lastname: Pelaprat
authors.forename: J
authors.initials: J
authors.lastname: Mazella
authors.forename: J
authors.initials: J
authors.lastname: Martinez
authors.forename: W
authors.initials: W
authors.lastname: Rostène
authors.forename: J
authors.initials: J
authors.lastname: Costentin
mesh_terms: D000595:Amino Acid Sequence; D000700:Analgesics / Q000494:pharmacology; D000818:Animals; D000831:Animals, Newborn; D001921:Brain / Q000166:cytology / Q000378:metabolism*; D002460:Cell Line; D007036:Hypothermia, Induced; D051379:Mice; D008969:Molecular Sequence Data; D009474:Neurons / Q000187:drug effects / Q000378:metabolism; D009496:Neurotensin / Q000031:analogs & derivatives / Q000737:chemistry / Q000494:pharmacology*; D009842:Oligopeptides / Q000737:chemistry / Q000494:pharmacology*; D051381:Rats; D018028:Receptors, Neurotensin / Q000145:classification* / Q000187:drug effects; D013329:Structure-Activity Relationship
chemical_list: D000700:Analgesics; D009842:Oligopeptides; D018028:Receptors, Neurotensin; D009496:Neurotensin